Validation of TRansanal Irrigation Adherence scaLe (TRIAL)

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jan 28, 2025

Keywords

ClinConnect Summary

The TRIAL study is looking to improve how we understand and support patients who use transanal irrigation (TAI), a method that helps people with bowel movement issues, like constipation or fecal incontinence. TAI is often recommended when other treatments haven’t worked. While many patients find TAI helpful, not everyone continues to use it long-term. This study aims to create a simple questionnaire that can help identify patients who are struggling to stick with the treatment. By understanding why some patients stop using TAI, healthcare providers can better support them and improve their experiences.

To participate in this study, individuals should be adults aged 65 and older who have been using TAI for at least a month and have issues related to bowel movements, whether from neurological conditions (like spinal cord injuries) or other reasons. Participants should be able to understand the study and give their consent to participate. Throughout the study, participants will fill out the new questionnaire and share their experiences with TAI, which will help researchers understand how to make this treatment work better for everyone.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • Patients using ICT for at least 1 month
• • Patients with anorectal disorders of neurological or neurological or non-neurological origin
• • Patients whose indication for TCI is constipation, anorectal and/or fecal incontinence.
• • Adult patients
• • Informed patients who do not object to participating in the study.
• • Exclusion criteria
• • Language barrier and comprehension difficulties
• • Patients under legal protection